Aziwin

Aziwin is a branded formulation of azithromycin, a macrolide antibiotic developed and marketed by Bal Pharma. It is a small molecule that functions by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. Aziwin is indicated for the treatment of various bacterial infections, including middle ear infections (otitis media), throat infections (pharyngitis), bronchitis, sinusitis, skin and soft tissue infections, pneumonia, typhoid, and certain sexually transmitted infections like gonorrhea and chancroid. It is available in multiple oral dosage forms, including tablets, syrups, and suspensions, and is a leading brand in Bal Pharma's anti-infectives portfolio in India.

Brand names

Aziwin

Other names

azithromycin